TheraDiag SA (ALTER):医療機器:M&Aディール及び事業提携情報

【英語タイトル】TheraDiag SA (ALTER) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C11399)・商品コード:DATA904C11399
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:45
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company serves autoimmune disease diagnostic markets. Theradiag is headquartered in Paris, France.

TheraDiag SA (ALTER) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
TheraDiag SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7
TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
TheraDiag SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
TheraDiag SA, Medical Equipment, Deal Details 11
Partnerships 11
Miraca Life Sciences Enters into Licensing Agreement with Theradiag 11
TheraDiag Enters into Agreement with Biogaran 12
Theradiag Enters into Distribution Agreement with HOB Biotech 13
HOB Biotech Enters into Distribution Agreement with Theradiag 14
TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 15
Theradiag Enters Into Co-Development Agreement With CNRS, IGMM And University of Montpellier 16
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 17
TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 18
TheraDiag Enters Into Agreement With Splicos And French National Center for Research 19
Theradiag Enters Into Co-Development Agreement With Sebia For New Diagnostic Kit 20
Equity Offering 21
TheraDiag Raises USD4.5 Million in Private Placement of Shares 21
TheraDiag Raises USD2.78 Million in Private Placement of Shares 22
TheraDiag Raises Funds in IPO of Shares 23
TheraDiag SA – Key Competitors 24
TheraDiag SA – Key Employees 25
TheraDiag SA – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Strategy And Business Planning 27
Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 27
Financial Announcements 28
Sep 19, 2018: Theradiag: 2018 interim results and business update 28
Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 30
Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 32
Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 33
Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 34
Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 36
Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 37
Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 38
Mar 01, 2017: THERADIAG: Full-year 2016 results 39
Corporate Communications 41
Oct 09, 2018: Evolution of Theradiag’s governance 41
Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag’s Board of Directors 42
Legal and Regulatory 43
Jan 19, 2018: Miraca Life Sciences, Theradiag’s partner in the USA, becomes Inform Diagnostics 43
Product News 44
Mar 28, 2017: Sixth test in Theradiag’s monitoring range launched in the USA 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
TheraDiag SA, Medical Equipment, Key Facts, 2017 2
TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
TheraDiag SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7
TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
TheraDiag SA, Deals By Market, 2012 to YTD 2018 9
TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Miraca Life Sciences Enters into Licensing Agreement with Theradiag 11
TheraDiag Enters into Agreement with Biogaran 12
Theradiag Enters into Distribution Agreement with HOB Biotech 13
HOB Biotech Enters into Distribution Agreement with Theradiag 14
TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 15
Theradiag Enters Into Co-Development Agreement With CNRS, IGMM And University of Montpellier 16
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 17
TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 18
TheraDiag Enters Into Agreement With Splicos And French National Center for Research 19
Theradiag Enters Into Co-Development Agreement With Sebia For New Diagnostic Kit 20
TheraDiag Raises USD4.5 Million in Private Placement of Shares 21
TheraDiag Raises USD2.78 Million in Private Placement of Shares 22
TheraDiag Raises Funds in IPO of Shares 23
TheraDiag SA, Key Competitors 24
TheraDiag SA, Key Employees 25
TheraDiag SA, Subsidiaries 26

List of Figures
TheraDiag SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TheraDiag SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
TheraDiag SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
TheraDiag SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★調査レポート[TheraDiag SA (ALTER):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C11399)販売に関する免責事項を必ずご確認ください。
★調査レポート[TheraDiag SA (ALTER):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆